CAP-100
Product Specifications
Target
CCR
Related Pathways
GPCR/G Protein, Microbiology/Virology, Immunology/Inflammation
Bioactivity
CAP-100 is a monoclonal antibody targeting CCR7. It neutralizes the ligand binding site and signaling of CCR7. This compound effectively inhibits migration, extravasation, homing, and survival in chronic lymphocytic leukemia (CLL) samples induced by CCR7. CAP-100 can mediate potent tumor cell killing through host immune mechanisms and exhibits favorable toxicity profiles in related hematopoietic cell subsets. It is involved in research on antitumor activity and diseases like chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6405542-01 0.1 mL
ADCYAP1R1 (Pituitary Adenylate Cyclase-activating Polypeptide Type I Receptor, PAC1, PAC1R, PACAPR, PACAPRI) (APC)
Sign In for Pricing
View Details MBS6405542-02 5x 0.1 mL
ADCYAP1R1 (Pituitary Adenylate Cyclase-activating Polypeptide Type I Receptor, PAC1, PAC1R, PACAPR, PACAPRI) (APC)
Sign In for Pricing
View Details F603760 10 mg
(2S,5S)-Fmoc-5-amino-1,2,4,5,6,7-hexahydro-azepino [3,2,1-hi] indole-4-one-2-carboxylic Acid
Sign In for Pricing
View Details QP12077-10ug 10ug
Recombinant Influenza H1N1 Puerto Rico Recombinant Protein, Untagged, Insect-10ug
Sign In for Pricing
View Details